← Insider Monitor
IONIS PHARMACEUTICALS INC logo
IONS

IONIS PHARMACEUTICALS INC

Nasdaq · Pharmaceutical Preparations

2
Insider trades
0
Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

Ionis Pharmaceuticals develops RNA-targeted therapeutics based on antisense oligonucleotide technology to treat diseases including neurological, cardiovascular, and rare genetic disorders, both independently and through partnerships with other pharmaceutical companies.

Industry
Pharmaceutical Preparations
Headquarters
Carlsbad, CA
Exchange
Nasdaq

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

InsiderTypeValueDate
Devers Shannon L.EVP, Chief Human Resources OfcSell$59KOct 16, 2026
Swayze EricEVP ResearchSell$2KOct 16, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for IONS.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable IONS activity by email

Free alerts for the insider and congressional trades worth watching.

SMS is optional: we only save your number if you check the consent box and provide a valid number. US mobile numbers only.

SMS Terms and Privacy Policy.

By submitting your email address, you will receive a free subscription to the MySmarTrend e-letter, and offers from us and our affiliates that we think might interest you. You can unsubscribe at any time. Privacy Policy.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.